Lupus Education Alliance Program

Study Purpose

The purpose of this study is to evaluate the evaluate the effect of education-only vs.#46; navigation interventions on COVID-19 testing and vaccination for people with systemic lupus erythematosus.

Recruitment Criteria

Accepts Healthy Volunteers

Healthy volunteers are participants who do not have a disease or condition, or related conditions or symptoms

Study Type

An interventional clinical study is where participants are assigned to receive one or more interventions (or no intervention) so that researchers can evaluate the effects of the interventions on biomedical or health-related outcomes.

An observational clinical study is where participants identified as belonging to study groups are assessed for biomedical or health outcomes.

Searching Both is inclusive of interventional and observational studies.

Eligible Ages 18 Years and Over
Gender All
More Inclusion & Exclusion Criteria

Inclusion Criteria:

  • - Living with systemic lupus erythematosus (SLE), - At least 18 years of age, - Ability to speak and understand English, and.
- Live, work, or seek care in Alabama or Louisiana

Trial Details

Trial ID:

This trial id was obtained from, a service of the U.S. National Institutes of Health, providing information on publicly and privately supported clinical studies of human participants with locations in all 50 States and in 196 countries.


Phase 1: Studies that emphasize safety and how the drug is metabolized and excreted in humans.

Phase 2: Studies that gather preliminary data on effectiveness (whether the drug works in people who have a certain disease or condition) and additional safety data.

Phase 3: Studies that gather more information about safety and effectiveness by studying different populations and different dosages and by using the drug in combination with other drugs.

Phase 4: Studies occurring after FDA has approved a drug for marketing, efficacy, or optimal use.

Lead Sponsor

The sponsor is the organization or person who oversees the clinical study and is responsible for analyzing the study data.

Tulane University
Principal Investigator

The person who is responsible for the scientific and technical direction of the entire clinical study.

Principal Investigator Affiliation N/A
Agency Class

Category of organization(s) involved as sponsor (and collaborator) supporting the trial.

Overall Status Recruiting
Countries United States

The disease, disorder, syndrome, illness, or injury that is being studied.

Systemic Lupus Erythematosus, COVID-19
Arms & Interventions


Experimental: Navigation

COVID education for people with lupus and tailored guidance in vaccination and testing for COVID and making appointments.

Active Comparator: Education

COVID education for people with lupus.


Behavioral: - Navigation

COVID education for people with lupus plus tailored guidance in ordering COVID tests and making testing and vaccination appointments.

Behavioral: - Education

COVID education for people with lupus.

Contact a Trial Team

If you are interested in learning more about this trial, find the trial site nearest to your location and contact the site coordinator via email or phone. We also strongly recommend that you consult with your healthcare provider about the trials that may interest you and refer to our terms of service below.

Tulane University, New Orleans, Louisiana




Tulane University

New Orleans, Louisiana, 70112

Site Contact

David Chae, ScD

[email protected]